Skip to main content

Table 2 Univariate and multivariate analysis of prognostics factors for recurrence in NBNC-HCC patients after curative resection

From: Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection

Variable

Comparison

Univariate

Multivariate

HR (95%CI)

p value

HR (95%CI)

p value

Age (years)

> 60 vs ≦ 60

1.316 (0.815–2.125)

0.216

  

Sex

Male vs. Female

1.220 (0.698–2.131)

0.485

  

DM history

Yes vs. no

1.286 (0.800–2.068)

0.299

  

Hypertension

Yes vs. no

1.184 (0.694–2.020)

0.536

  

Alcoholic history

Yes vs. no

1.353 (0.748–2.446)

0.318

  

AFP (ng/ml)

> 200 vs. ≦ 200

2.065 (1.149–3.710)

0.015

2.070 (1.114–3.848)

0.021

Platelet (\({10}^{9}\)/L)

≦ 150 vs. > 150

1.264 (0.754–2.119)

0.375

  

Albumin (g/dL)

≦ 3 vs. > 3

1.358 (0.833–2.215)

0.220

  

Liver cirrhosis

Yes vs. no

0.950 (0.552–1.635)

0.853

  

Child–Pugh grade

B vs. A

1.216 (0.682–2.168)

0.508

  

ALBI grade

II/III vs. I

1.052 (0.662–1.671)

0.831

  

Tumor size (cm)

> 5 vs. ≦ 5

1.024 (0.634–1.653)

0.923

  

Tumor no

Multiple vs. single

2.847 (0.892–9.084)

0.077

10.770 (2.513–46.153)

0.001

BCLC stage

B vs. 0/A

1.004 (0.625–1.615)

0.985

  

Liver fat content (%)

> 30 vs. ≦ 30

1.472 (0.811–2.673)

0.204

  

Microvascular invasion

Yes vs. no

0.798 (0.479–1.329)

0.386

  

pTNM stages

II + III vs. I

2.084 (1.302–3.336)

0.002

1.962 (1.199–3.210)

0.007

Histology stages

Poor vs. well/moderate

1.699 (0.682–4.232)

0.255

  
  1. DM diabetes mellitus, AST aspartate aminotransferase, ALBI albumin–bilirubin, BCLC Barcelona Clinic Liver Cancer, pTNM pathological tumor-node-metastasis